Innovations In Medicine
Stay current with the science shaping the future of healthcare with Innovations in Medicine. Here, leading clinicians, researchers, and scientific experts come together to examine emerging evidence and to share their expert perspectives across therapeutic areas so that you can gain a deeper understanding of today's clinical landscape and tomorrow's standards of care.
1-14 of 14
Seeing the Full Picture of ADHD: Beyond Core Symptoms
Innovations In MedicineSeeing the Full Picture of ADHD: Beyond Core Symptoms
Andrew J. Cutler, MD
Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC
Understanding Sedation and Somnolence with Brexpiprazole in Agitation: What the Data Show
Innovations In MedicineUnderstanding Sedation and Somnolence with Brexpiprazole in Agitation: What the Data Show
George Grossberg, MD
Marc E. Agronin, MD
Two Lenses on Migraine: Managing Incomplete Acute Treatment Response
Innovations In MedicineTwo Lenses on Migraine: Managing Incomplete Acute Treatment Response
Fallon Schloemer, DO
Susan Hutchinson, MD
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Jennifer Caudle, DO, FACOFP
Ida Micaily, MD
Jeffrey Varanelli, OD
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Charles Turck, PharmD, BCPS, BCCCP
Jun Gong, MD
- advertisement
Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Medical Industry FeatureChallenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Jaimini Patel, PharmD, BCCCP
Sayna Norouzi, MD
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Alexandria May, PharmD, BCPS
Sunnie Kim, MD
Courtney Crawford, MD, FACS
Raj Maturi, MD
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry FeatureTau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Yuval Zabar, MD
Michelle Mielke, PhD
Henrik Zetterberg, MD, PhD
Immunotherapy Advances in Early-Stage Upper GI Cancers: Key Trial Insights
Project Oncology®Immunotherapy Advances in Early-Stage Upper GI Cancers: Key Trial Insights
Jennifer Caudle, DO, FACOFP
Ronan J. Kelly MD, MBA, FASCO
Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Project Oncology®Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Jennifer Caudle, DO, FACOFP
Samuel Klempner, MD
Nataliya Uboha, MD, PhD
- advertisement
Advancing Biomarker Testing Strategies in Upper GI Cancers: From PD-L1 to FGFR2b
Project Oncology®Advancing Biomarker Testing Strategies in Upper GI Cancers: From PD-L1 to FGFR2b
Charles Turck, PharmD, BCPS, BCCCP
Rutika J. Mehta, MD, MPH
How Information Technology Will Revolutionize Mental Health Care
Everyday Family MedicineHow Information Technology Will Revolutionize Mental Health Care
Matt Birnholz, MD
